Soleno Therapeutics, Inc. (FRA:6XC)
Germany
· Delayed Price · Currency is EUR 45.00
-0.04 (-0.09%)
At close: Dec 5, 2025
Soleno Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -78.45 | -175.85 | -38.99 | -24.07 | -30.91 | -24.64 | Upgrade
|
| Depreciation & Amortization | 2.01 | 1.99 | 1.96 | 1.96 | 1.96 | 1.95 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.73 | -4.9 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 64.13 | 99.96 | 5.95 | 2.53 | 3.28 | 1.5 | Upgrade
|
| Other Operating Activities | 5.72 | 3.69 | 3.22 | -0.45 | -0.95 | -7.01 | Upgrade
|
| Change in Accounts Receivable | -25.51 | - | - | - | - | - | Upgrade
|
| Change in Inventory | -6.01 | - | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 1.9 | 5.67 | 1.37 | -1.48 | -0.24 | 1.49 | Upgrade
|
| Change in Other Net Operating Assets | 14 | 0.35 | 1.56 | 0.72 | -0.91 | 1.48 | Upgrade
|
| Operating Cash Flow | -25.9 | -69.1 | -24.94 | -20.78 | -27.77 | -25.22 | Upgrade
|
| Capital Expenditures | -0.02 | -0.22 | - | -0.01 | -0.02 | -0.01 | Upgrade
|
| Investment in Securities | -69.96 | -225.46 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -69.98 | -225.68 | - | -0.01 | -0.02 | -0.01 | Upgrade
|
| Long-Term Debt Issued | - | 49.89 | - | - | - | - | Upgrade
|
| Total Debt Issued | 49.89 | 49.89 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -0.01 | -0.02 | Upgrade
|
| Total Debt Repaid | - | - | - | - | -0.01 | -0.02 | Upgrade
|
| Net Debt Issued (Repaid) | 49.89 | 49.89 | - | - | -0.01 | -0.02 | Upgrade
|
| Issuance of Common Stock | 244.33 | 163.14 | 180.02 | 14.11 | - | 53.74 | Upgrade
|
| Repurchase of Common Stock | -0.03 | - | - | -0.02 | -0.12 | - | Upgrade
|
| Other Financing Activities | -0.06 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | 294.12 | 213.03 | 180.02 | 14.09 | -0.13 | 53.72 | Upgrade
|
| Net Cash Flow | 198.25 | -81.75 | 155.08 | -6.7 | -27.92 | 28.49 | Upgrade
|
| Free Cash Flow | -25.92 | -69.31 | -24.94 | -20.79 | -27.79 | -25.23 | Upgrade
|
| Free Cash Flow Per Share | -0.53 | -1.73 | -1.51 | -2.48 | -5.23 | -6.04 | Upgrade
|
| Levered Free Cash Flow | -5.7 | -7.47 | -12.82 | -11.71 | -15.79 | -13.3 | Upgrade
|
| Unlevered Free Cash Flow | -3 | -7.33 | -12.82 | -11.71 | -15.79 | -13.3 | Upgrade
|
| Change in Working Capital | -15.61 | 6.02 | 2.93 | -0.76 | -1.15 | 2.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.